Asset Management
Compare Stocks
2 / 10Stock Comparison
BLK vs IVZ
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
BLK vs IVZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $166.54B | $12.15B |
| Revenue (TTM) | $20.41B | $6.38B |
| Net Income (TTM) | $6.10B | $-243M |
| Gross Margin | 49.4% | 43.2% |
| Operating Margin | 37.1% | -10.9% |
| Forward P/E | 20.2x | 10.6x |
| Total Debt | $14.22B | $10.12B |
| Cash & Equiv. | $12.76B | $1.98B |
BLK vs IVZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| BlackRock, Inc. (BLK) | 100 | 203.1 | +103.1% |
| Invesco Ltd. (IVZ) | 100 | 343.2 | +243.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BLK vs IVZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BLK carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 15 yrs, beta 1.28, yield 1.9%
- Rev growth 14.3%, EPS growth 15.1%
- 246.4% 10Y total return vs IVZ's 23.3%
IVZ is the clearest fit if your priority is defensive.
- Beta 1.67, yield 3.0%, current ratio 43.01x
- Lower P/E (10.6x vs 20.2x)
- +98.8% vs BLK's +19.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.3% NII/revenue growth vs IVZ's 5.1% | |
| Value | Lower P/E (10.6x vs 20.2x) | |
| Quality / Margins | Efficiency ratio 0.1% vs IVZ's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 1.28 vs IVZ's 1.67, lower leverage | |
| Dividends | 1.9% yield, 15-year raise streak, vs IVZ's 3.0% | |
| Momentum (1Y) | +98.8% vs BLK's +19.7% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs IVZ's 0.5% |
BLK vs IVZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BLK vs IVZ — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BLK leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BLK is the larger business by revenue, generating $20.4B annually — 3.2x IVZ's $6.4B. BLK is the more profitable business, keeping 31.2% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $20.4B | $6.4B |
| EBITDAEarnings before interest/tax | $8.3B | $1.2B |
| Net IncomeAfter-tax profit | $6.1B | -$243M |
| Free Cash FlowCash after capex | $3.9B | $1.9B |
| Gross MarginGross profit ÷ Revenue | +49.4% | +43.2% |
| Operating MarginEBIT ÷ Revenue | +37.1% | -10.9% |
| Net MarginNet income ÷ Revenue | +31.2% | -4.4% |
| FCF MarginFCF ÷ Revenue | +23.0% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -22.7% | +34.2% |
Valuation Metrics
IVZ leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, IVZ's 16.5x EV/EBITDA is more attractive than BLK's 20.7x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $166.5B | $12.2B |
| Enterprise ValueMkt cap + debt − cash | $168.0B | $20.3B |
| Trailing P/EPrice ÷ TTM EPS | 25.56x | -17.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.21x | 10.64x |
| PEG RatioP/E ÷ EPS growth rate | 3.15x | — |
| EV / EBITDAEnterprise value multiple | 20.73x | 16.53x |
| Price / SalesMarket cap ÷ Revenue | 8.16x | 1.91x |
| Price / BookPrice ÷ Book value/share | 3.30x | 0.95x |
| Price / FCFMarket cap ÷ FCF | 35.43x | 8.43x |
Profitability & Efficiency
BLK leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
BLK delivers a 9.9% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-2 for IVZ. BLK carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to IVZ's 0.78x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.9% | -1.7% |
| ROA (TTM)Return on assets | +3.7% | -0.9% |
| ROICReturn on invested capital | +9.9% | -2.3% |
| ROCEReturn on capital employed | +5.8% | -2.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.29x | 0.78x |
| Net DebtTotal debt minus cash | $1.5B | $8.1B |
| Cash & Equiv.Liquid assets | $12.8B | $2.0B |
| Total DebtShort + long-term debt | $14.2B | $10.1B |
| Interest CoverageEBIT ÷ Interest expense | 9.27x | -6.19x |
Total Returns (Dividends Reinvested)
IVZ leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BLK five years ago would be worth $13,522 today (with dividends reinvested), compared to $11,058 for IVZ. Over the past 12 months, IVZ leads with a +98.8% total return vs BLK's +19.7%. The 3-year compound annual growth rate (CAGR) favors IVZ at 22.3% vs BLK's 20.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -0.5% | +2.3% |
| 1-Year ReturnPast 12 months | +19.7% | +98.8% |
| 3-Year ReturnCumulative with dividends | +76.6% | +83.0% |
| 5-Year ReturnCumulative with dividends | +35.2% | +10.6% |
| 10-Year ReturnCumulative with dividends | +246.4% | +23.3% |
| CAGR (3Y)Annualised 3-year return | +20.9% | +22.3% |
Risk & Volatility
Evenly matched — BLK and IVZ each lead in 1 of 2 comparable metrics.
Risk & Volatility
BLK is the less volatile stock with a 1.28 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IVZ currently trades 92.4% from its 52-week high vs BLK's 88.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.28x | 1.67x |
| 52-Week HighHighest price in past year | $1219.94 | $29.61 |
| 52-Week LowLowest price in past year | $906.57 | $14.04 |
| % of 52W HighCurrent price vs 52-week peak | +88.0% | +92.4% |
| RSI (14)Momentum oscillator 0–100 | 55.3 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 798K | 5.1M |
Analyst Outlook
Evenly matched — BLK and IVZ each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BLK as "Buy" and IVZ as "Hold". Consensus price targets imply 22.2% upside for BLK (target: $1312) vs 8.7% for IVZ (target: $30). For income investors, IVZ offers the higher dividend yield at 3.04% vs BLK's 1.91%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $1311.78 | $29.72 |
| # AnalystsCovering analysts | 33 | 28 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | +3.0% |
| Dividend StreakConsecutive years of raises | 15 | 4 |
| Dividend / ShareAnnual DPS | $20.46 | $0.83 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | +15.3% |
BLK leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IVZ leads in 2 (Valuation Metrics, Total Returns). 2 tied.
BLK vs IVZ: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BLK or IVZ a better buy right now?
For growth investors, BlackRock, Inc.
(BLK) is the stronger pick with 14. 3% revenue growth year-over-year, versus 5. 1% for Invesco Ltd. (IVZ). BlackRock, Inc. (BLK) offers the better valuation at 25. 6x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate BlackRock, Inc. (BLK) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BLK or IVZ?
On forward P/E, Invesco Ltd.
is actually cheaper at 10. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BLK or IVZ?
Over the past 5 years, BlackRock, Inc.
(BLK) delivered a total return of +35. 2%, compared to +10. 6% for Invesco Ltd. (IVZ). Over 10 years, the gap is even starker: BLK returned +246. 4% versus IVZ's +23. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BLK or IVZ?
By beta (market sensitivity over 5 years), BlackRock, Inc.
(BLK) is the lower-risk stock at 1. 28β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 30% more volatile than BLK relative to the S&P 500. On balance sheet safety, BlackRock, Inc. (BLK) carries a lower debt/equity ratio of 29% versus 78% for Invesco Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — BLK or IVZ?
By revenue growth (latest reported year), BlackRock, Inc.
(BLK) is pulling ahead at 14. 3% versus 5. 1% for Invesco Ltd. (IVZ). On earnings-per-share growth, the picture is similar: BlackRock, Inc. grew EPS 15. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BLK or IVZ?
BlackRock, Inc.
(BLK) is the more profitable company, earning 31. 2% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 31. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BLK leads at 37. 1% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — BLK leads at 49. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BLK or IVZ more undervalued right now?
On forward earnings alone, Invesco Ltd.
(IVZ) trades at 10. 6x forward P/E versus 20. 2x for BlackRock, Inc. — 9. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BLK: 22. 2% to $1311. 78.
08Which pays a better dividend — BLK or IVZ?
All stocks in this comparison pay dividends.
Invesco Ltd. (IVZ) offers the highest yield at 3. 0%, versus 1. 9% for BlackRock, Inc. (BLK).
09Is BLK or IVZ better for a retirement portfolio?
For long-horizon retirement investors, BlackRock, Inc.
(BLK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 28), 1. 9% yield, +246. 4% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BLK: +246. 4%, IVZ: +23. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BLK and IVZ?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BLK is a mid-cap quality compounder stock; IVZ is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.